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Abstract: Near-triploid human tumors are frequently resistant to radio/chemotherapy through
mechanisms that are unclear. We recently reported a tight association of male tumor triploidy
with XXY karyotypes based on a meta-analysis of 15 tumor cohorts extracted from the Mitelman
database. Here we provide a conceptual framework of the digyny-like origin of this karyotype based
on the germline features of malignant tumors and adaptive capacity of digyny, which supports
survival in adverse conditions. Studying how the recombinatorial reproduction via diploidy can be
executed in primary cancer samples and HeLa cells after DNA damage, we report the first evidence
that diploid and triploid cell sub-populations constitutively coexist and inter-change genomes via
endoreduplicated polyploid cells generated through genotoxic challenge. We show that irradiated
triploid HeLa cells can enter tripolar mitosis producing three diploid sub-subnuclei by segregation
and pairwise fusions of whole genomes. Considering the upregulation of meiotic genes in tumors, we
propose that the reconstructed diploid sub-cells can initiate pseudo-meiosis producing two “gametes”
(diploid “maternal” and haploid “paternal”) followed by digynic-like reconstitution of a triploid
stemline that returns to mitotic cycling. This process ensures tumor survival and growth by (1) DNA
repair and genetic variation, (2) protection against recessive lethal mutations using the third genome.
Keywords: near-triploid cancer; radioresistance; chemoresistance; reprogramming; digyny;
polynuclear cancer cells; tripolar mitosis; pedogamy; tumor blastomeres
“All basic traits inherent in cancer cells are displayed in gametes and vice versa”
Janis-Olgerts Erenpreiss [1]
1. Introduction
Organismal triploidy in humans is known to be lethal and causes early spontaneous abortions [2].
In contrast, aneuploidy is a well-tolerated characteristic hallmark of most human tumors [3–5].
Moreover, many established tumor cell lines used as models for cancer research or pharmacological
studies exhibit near-triploidy [6] and many chemotherapy-resistant cancers display it in vivo [7–9].
In the accompanying article [10] we recently presented data for the origin of tumor triploidy based on
the in silico meta-analysis of 2928 karyotypes from 15 malignant solid tumor types of male patients
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from the Mitelman database [11]. We provided evidence that triploidy very likely initially occurs
through whole genome rearrangements when one paternal genome is added to two copies of the
maternal genome (XXY karyotype correlating with near-triploidy, r = 0.88, p < 0.001). Such a karyotype
can be formed by a digyny-like process (Figure 1). For female tumors, this karyotype should be
triploid XXX (~69XXX). To obtain this outcome, a separation of parental genomes and sister chromatid
non-disjunction in maternal genomes using an aberrant meiotic pathway can be presumed to occur at
some stage of tumor development that involves the gametogenic reprogramming of somatic tumor cells.
Figure 1. A conceptual schematic of the digyny-like formation of XXY triploid karyotypes in
somatic male tumors revealed in the Mitelman karyotypes database data [10,11]. The reprogrammed
male tumour cell triggers from G2-phase the aberrant molecular pathway of meiosis (here termed
pseudo-meiosis), undergoes recombination between cohesed sisters and homologues *, pseudo-meiosis
I segregating maternal, and paternal progenies with cohesed sister chromatids, reduction to haploidy
of the “paternal gamete” in the pseudo-meiosis II and its pedogamic fusion with the unreduced diploid
“maternal gamete” resulting in triploid “digynic parthenote”. * For recombination details, which are
aberrant, see [12].
Below we briefly review the literature data which may give a hint for tackling the problem of
cancer triploidy from this point. For a better understanding of the conceptual terms, we provide the
reader with a Glossary.
1.1. Glossary
Near-triploidy—DNA content of the stem line, determined in relation to G1 diploidy DNA
content, which is close to 1.5. [9,13]. For human karyotypes, near-triploidy is defined from the modal
chromosome number, close to 3n = 69 chromosomes [10]. The confidence interval is chosen depending
on the research object, method precision, and tasks.
Digyny—refers to the process of an unreduced maternal gamete becoming fertilized by a haploid
sperm (reduced paternal gamete). The result of digyny is a triploid zygote.
Unreduced maternal gamete—the oocyte which does not undergo the second meiotic division and
remains diploid.
Digyny-like—the process similar to digyny supposedly occurring in tumor cells of somatic origin
reprogrammed to the epigenetic state of the germline (“maternal and paternal gametes”).
Parthenote—an organism produced from an unfertilized ovum, which in human is incapable of
developing beyond the early embryonic stages.
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Germline—germ cells each descended or developed from earlier cells in the series, regarded as
continuing through successive generations of an organism (life-cycles).
Endoreduplication (also referred to as endocycling) is the replication of the nuclear genome in the
absence of mitosis, which leads to elevated nuclear gene content and polyploidy.
Pseudo-meiosis (somatic meiosis) is an asexual ploidy cycle.
Ploidy cycle—includes the doubling(s) of ploidy (asexual by endoreduplication or sexual by
fertilization) and its halving in reduction division(s). “The ploidy cycle provides the potential for
orderly reduction which needs (1) cohesion of sister chromatids; (2) omission of DNA replication; and
(3) pairing and recombination of homologous chromosomes, which is usually present but may be
optional for somatic reduction” [14].
Meiomitosis—currently a poorly defined term used in particular for mitotic tumor cells, which
undergo endoreduplication and in which the meiotic machinery is partially expressed. In these cells,
chiasma occurs and sister chromatids are fully or partially linked together with cohesion. These cells
reduce ploidy and again return to mitosis [15,16].
Parasexual process—any form of reproduction in which the recombination of genes occurs by a
process other than the gamete fusion [17].
Pedogamy—reproduction by the fusion of gametes derived from the same parent cell [18].
Triploid bridge—an epistatic synonym of digyny. Unreduced egg cell formation in diploids
represents the first step (a bridge) toward asexual reproduction [19]. It appears that a triploid bridge
between sexual diploidy and asexual polyploidy can evolutionarily operate in both directions [20].
Neosis—the term introduced by R. Rajaraman [21,22] for a parasexual process in tumor
cells resuming immortality and proliferation potential by particular de-polyploidization cycles of
polyploidized senescing mother cells.
Diplochromosome—a chromosome containing four chromatids produced by two rounds of
replication without chromatid separation (due to their unresolved cohesion).
1.2. Digyny in Developmental Biology and Human Diploid-Triploid Mosaicism
In developmental biology, the XXY triploid karyotype is referred to as “digyny”, which is the
most common form of whole genome aneuploidy in plants and animals [20,23,24], however, it is rarely
encountered in human pathology [25]. Digyny most often arises from aberrant fertilization of an
unreduced diploid egg cell by a monoploid sperm leading to a sterile triploid organism [26]. Two
rounds of endoreplication before meiosis instead of one also often favor failed reduction of the gamete
in the unisexual reproduction [27]. In rare pathology of diploid-triploid human mosaics, a delayed
digyny was also described—by incorporation of a pronucleus from a second polar body into one
embryonic blastomere developed from an unreduced gamete [28].
In nature, a “triploid bridge” to asexual reproduction appears as an adaptation to adverse
environmental conditions or can be artificially induced by them. In such cases, sexual organisms
produce an increased number of unreduced oocytes so that after fertilization triploid sterile individuals
appear [29]. Development “with a purpose” of the three-genome organisms seems strange because
meiosis ensuring a reproductive process by recombination and ordered reduction “takes only two to
tango” [30], while the third is odd. However, triploid individuals have two advantages—(1) the third
genome is compatible with mitosis and diminishes the frequency of recessive lethal mutations and so
favors clonal survival in a poor environment, (2) a sterile triploid conserves the energy otherwise needed
for sex [20,24]. Therefore, the short-term advantage of digyny is even exploited in fish aquaculture
when the female fish are treated with hydrostatic pressure, cold- or heat-shock to prevent their oocyte
maturation in order to produce artificial triploid food-fish after fertilization [31].
From this data, the constitutive karyotype of near-triploid human male tumors ~69XXY found by
us in silico in male malignant tumors and known chemoresistance of cancer triploidy motivated us to
hypothesize that a process similar to digyny can occur in somatic tumor cells. Digyny is associated
with gametogenesis. How can it be related to cancer?
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1.3. Cancer Reprogramming To the Embryonality
Cancer (stem) cells can be reprogrammed to the epigenetic state of the cleavage embryo or
even the germ cell [32]. This trait heralded by expression of totipotency cycle gene POU5F1 [33],
is started with the emergence of illicit tetraploidy triggered from G2-phase/mitotic slippage, particularly
enhanced by genotoxic stress [34–36]. The reprogramming to the embryonal stemness of tumor cells
was found in aggressive tumors in vivo [37] and recently documented by single-cell transcriptome
sequencing in chemoresistant basal breast cancer and melanoma [38,39]. These facts correspond to the
embryological theory of cancer and its gametogenic variant, known since the 19th century [1,40–44]
and coming into power again in the 21st century [35,36,45–47]. Cancer cells were hypothesized to
undergo a life-cycle-like process of reversible polyploidy for self-renewing “neosis” [21,22], producing
a “germ” [35,48] comparable with sporogenesis [49,50]. In the following, this process will be termed
pseudo-meiosis as displaying common features with meiosis. Pseudo-meiosis of somatic tumor cells is
likely part of this asexual life-cycle as the relevant processes including cohesion of sister chromatids,
recombination, and reduction divisions omitting the S-phase, with an expression of relevant meiotic
genes, were reported for multiple treatment-resistant tumor cell lines [12,51–54], also in vivo [55,56].
Still, the details of the whole process (currently also termed meiomitosis) remain obscure [15,16].
1.4. Segregation of Haploid Genomes Is Coupled to Endoreduplication by Spindle Dysfunction
To get from diploidy to the digyny-like triploidy, segregation of haploid genomes should occur.
Normally, it takes place in sexual meiosis but has been also described in the asexual life cycles,
with meiotic elements. Segregation of haploid genomes by cycling polyploidy in the life cycle of
radiolarian Aulacantha was first described by C. Grell [57]. This multi-step process was shown by
him and further by others to operate with bi-chromatid chromosomes linked end-to-end in haploid
genome entities, undergoing polyploidization (through a dysfunctional spindle), somatic pairing,
followed by multipolar and bipolar mitoses, and final release of haploid spores [57,58]. Separation of
autonomous duplicated parental haploid sets in diploid tissues induced by colchicine (which causes
spindle dysfunction) or spontaneously by stress is known for plants, fungi, animals, [59], senescing cells,
and was related by Walen [60,61] to human cancer. We recently provided evidence from human diploid
embryonal carcinoma that segregation of parental genomes composed of bi-chromatid chromosomes
with closed telomere ends, linked end-to-end, in a peculiar pro-metaphase possessing a dysfunctional
mitotic spindle and forming a tetraploid cell, is followed by parental genome fusion and conjugation
of homologues, recombination, and reduction divisions that restore diploidy [12]. From this data, it
follows that separation of haploid genomes is likely evolutionary pre-programmed from the asexual
life-cycles of haploid protists. It is coupled to endoreduplication, the cohesion of sister chromatids,
and needs a dysfunctional spindle, which otherwise would separate them.
1.5. The Spindle Checkpoint Is Weak in the Preimplantation Embryo and Polyploidizing Tumor Cells
It is now established that a spindle arrest checkpoint is not fully functioning during the first four
embryonal cleavage stages. The early blastomeres are genetically unstable [62–64] and frequently
mixoploidy in vitro [65]. Moreover, in Drosophila the whole embryo remains multinucleated until
de-polyploidization by cellularization, which occurs only at the blastocyst stage [66].
Importantly, during the first four cleavage divisions, along with the weakness of the spindle
checkpoint, the parental genomes in normal mouse and human embryo also keep in mitotic plates as
separate groups [67], that is while the blastomeres remain totipotent. Interestingly, the polyploidization
of human tumor cells induced by the genotoxic challenge also usually proceeds until “a totipotency
checkpoint”, the ploidy number (four endocycles) equivalent of the 32-cell morula, from which
de-polyploidization including cellularization producing resistant mitotic progeny starts from day
~6–7 [68–71]. The multinucleated giant single cells matured to this point are capable of initiating tumor
growth upon transplantation in animals [50,72,73].
Genes 2019, 10, 551 5 of 20
1.6. Digynic Zygotes in Human In Vitro Fertilization (IVF) Clinic
Interesting information for our analysis of cancer triploidy is coming from the IVF clinic.
Triploid zygotes are often observed there (with a frequency of 12%) and the most frequent cause is
digyny—fertilization of unreduced oocytes by a haploid sperm [74]. Digynic triploid zygotes most
often divide by tripolar mitosis [75].
In summary, the literature analysis suggests that endoreduplication coupled with reprogramming
to embryonic germline totipotency and separation of parental haploid genomes through the
dysfunctional spindle, and likely the tripolar mitosis, with poorly explored relationship to
pseudo-meiosis, may be involved in the origin of digyny-like whole genome triploidy in
radio-chemoresistant human tumors.
2. Materials and Methods
2.1. Patient Samples, Cell Lines, and Treatment
Breast cancer patient tissue specimens were collected after the patient’s informed consent was
obtained in accordance with the regulations of the Committee of Medical Ethics of Latvia [9]. HeLa
cervix carcinoma cells and Namalwa Burkitt’s lymphoma cells were obtained from ATCC. The HeLa cell
culture was grown as a monolayer in flasks or on glass coverslips in F-10 medium (Hyclone Pittsburgh,
PA, USA) containing 10% fetal bovine serum (FBS) (Hyclone, Pittsburgh, PA, USA) and antibiotics
(Penicillin-streptomycin, Sigma P4333, Ronkonkoma, NY, USA) at 37 ◦C in a 5% CO2 humidified
incubator (Sanyo, Watford, UK). ATCC cells were grown as suspension cultures in RPMI-1640 medium
supplied with 10% FBS (Sigma).
For the experimental studies shown here, cells were maintained in the log phase of growth, and
treated with a single, acute 10 Gy dose of gamma radiation using a Gulmay D3 225 X-ray source (Krefeld,
Germany) at a dose rate of 0.77 Gy/min. After irradiation, cell cultures were maintained by replenishing
culture medium every 2–3 days and sampled over a two-week period post-irradiation. For Aurora
B-kinase detection in some specified experiments, the proteasome inhibitor 10µM lactacystin was
added to the culture medium for 2 h before cell harvest.
2.2. Fluorescent In Situ Hybridization (FISH)
The fluorescent in situ hybridization (FISH) protocol has been described in detail previously [76].
In brief, HeLa cells were harvested, treated with 75 mM KCl at room temperature for 10 min and fixed
with five changes of methanol/glacial acetic acid (3:1). The cell suspension was dropped onto slides
and allowed to dry. Fluorescence labelled pericentric satellite DNA probes (Q-BIOgene–Molecular
Cytogenetics/Diagnostics, Illkirch Graffenstaden, France) specific for chromosomes #6, #10, and #X were
used and hybridized according to the manufacturer’s protocol. The cell nuclei were counterstained
with DAPI (4′,6-diamidino-2-phenylindole) (ThermoFisher, Waltham, MS, USA) and embedded in
the antifade mounting medium. The cover glass on the slides was sealed with rubber cement.
These chromosomes were chosen as containing three normal copies and not participating in clonal
markers [77]. The number of fluorescent chromosome labels per individual nuclei was counted in
500–800 cells 24 and 48 h after irradiation and compared to the non-irradiated control.
2.3. DNA Image Cytometry
Cells were grown on coverslips, prepared as cytospins or as smears and imprints on
poly-L-lysine-coated microscopy slides (from breast cancer material), air-dried and fixed in ethanol:
Acetone (1:1) for >30 min at 4 ◦C and then air-dried again. Slides were then hydrolyzed with 5N HCl
for 20 min at room temperature. They were further washed in distilled water (5 × 1 min) and stained for
10 min with 0.05% toluidine blue (TB) in 50% citrate-phosphate McIlvain buffer at pH 4. After staining,
samples were shortly rinsed in distilled water followed by blotting to dry and dehydration in butanol
for 2 × 3 min at 37 ◦C. Samples were then incubated twice in xylene for 3 min at room temperature
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before being embedded in DPX. Digital images were collected at 100 × 10 magnification using L03-10
microscope (Ergolux, Leitz, Germany) equipped with DXC 390P color video camera (Sony, Tokyo,
Japan) calibrated in the green channel. DNA content was measured as the integral optical density
(IOD), using Image-Pro Plus 4.1 software (Media Cybernetics, Rockville, MD, USA). The stoichiometry
of DNA staining was verified using the values obtained for metaphases compared to anaphases and
telophases (ratio 2:0); arbitrary diploid (2C) DNA values were averaged from measuring 50 anaphases
in non-treated tumor cells. The reference 2C DNA value and variation coefficient for DNA staining
method were assessed in normal human leukocytes (≈2%). The device error was estimated at 0.5%.
The integral error of the DNA staining for DNA index (DI) determination in breast cancer was assumed
10%; for HeLa mitotic cells the variation of the DNA C-value reached 20%.
2.4. Immunofluorescence
Immunofluorescence staining was performed as described [78]. The Aurora B kinase antibody
(ab2254) was purchased from Abcam (Cambridge, UK), α-Tubulin (T5168) from Sigma, and Lamin
B1 (sc-6216) from Santa Cruz (Dallas, TX, USA). For microscopic observations, a fluorescence light
microscope Ergolux L03-10 (Leitz) equipped with a color video camera (Sony DXC 390P, Tokyo, Japan)
was used (Objective ×100, magnification ×1000). To capture fluorescent images, in addition to separate
optical filters, a three-band BRG (blue, red, green) optical filter (Leica, Wetzlar, Germany) was used.
2.5. In Silico Study of the Mitelman Database
The in-silico study of the Mitelman database was performed as described in the accompanying
article [10,11]. Nota bene: For the sex chromosomes, chromothripsis was specifically filtered out by our
bioinformatic pipeline, to allow us to document whole genome rearrangements [10].
3. Results
After assuming that a digyny-like process can convert diploid tumor cells into triploidy “digynic
parthenotes”, we suggest as a working hypothesis, that on its side, the near-triploid tumor cell
line uses the endoreduplication platform to create the diploid stemline, capable of undergoing the
recombinatorial pseudo-meiosis and reciprocal exchange with “digyny”.
We report below some data relevant to this hypothesis from our studies of male tumors from the
Mitelman database and from chemoresistance study of breast cancer tumors in patients. Next, we
searched for the evidence and mechanisms of the reversible conversion of triploidy into diploidy in
the well-known tumor model cervical carcinoma HeLa. We provoked resistant near-triploid cervical
carcinoma HeLa cells (with a modal chromosome number 69 [79]) by one hit of ionizing irradiation
(10 Gy) to follow the cell division events over the two-week course.
3.1. A Triploid Cell-Line May Coexist with Cycling Diploidy in Patient Tumors
3.1.1. Male Tumors (Renal Carcinoma)
Analysis of histograms of modal chromosome numbers in large 15 cohorts of monoclonal tumor
types from the Mitelman database presented in [10] revealed near-diploid, near-triploid, and also
near-tetraploid karyotypes in each tumor type. One can suggest that “monoclonal” near-triploid
tumors could contain or give rise to a small amount of diploid and tetraploid sub-clones (which may
be hidden in a dormant state). Some examples of the reported polyclonal karyotypes from male
renal carcinoma with near-triploid XXY, diploid, and tetraploid clones from the Mitelman karyotype
database (exemplified in Table 1) are compatible with this assumption.
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Table 1. Some examples of the polyclonal karyotypes (numbered in columns) from male renal carcinoma
with near-triploid XXY, near-diploid, and near- tetraploid clones, extracted from the Mitelman karyotype
database. (Chr—modal chromosome number, Sex—sex chromosome complement).
Case Chr1 Sex1 Chr2 Sex2 Chr3 Sex3 Chr4 Sex4
1 70 XXY 46 XY 42 XXY 45 XXY
2 75 XXY 68 XXY 87 XXXXYY 48 XY
3 46 XX, -Y 45 XX, -Y 62 XX, -Y
4 74 XXY 46 X, -Y 46 XY
3.1.2. Female Tumors (Breast Cancer)
The coexistence of the cycling triploid with the cycling diploid stemline was clearly seen in our
study of breast cancer in patients [9]. In cases of chemoresistance, a cycling and endocycling triploidy
(3C, 6C, 12C, 24C) was found in each DNA cytometry histogram, both in the diagnostic biopsy and
material from the same patient post-neoadjuvant therapy (Figure S1). In one case (case 30), the triploid
clone evolved from a very small cycling sub-clone in initial tumor biopsy to become the dominant
stemline after non-successful chemotherapy (Figure S1). The study also revealed that in breast cancer
tumors with a near-triploid stemline the hyper-tetraploid cell fraction (DNA C value > 4.5) was 4-times
larger (p = 0.003) than in near-diploid tumors [9], indirectly pointing towards the role of endocycles in
the origin of triploidy. Similarly, Kim et al. [39], in a single cell study, noticed the emergence of the
triploid clone in the case of resistant to therapy basal breast cancer.
3.2. Diploid, Tetraploid, and Haploid Cell Nuclei Are Induced after Irradiation of Near-Triploid Cervical
Carcinoma HeLa Cells
The model of a single 10 Gy irradiation hit of HeLa cells has been previously established in
the prolonged life-imaging digital studies in the lab of Ianzini and MacKay [80], while HeLa cell
response in this model during two weeks post-damage using life-imaging, DNA cytometry, and
immunofluorescence was further reported in the joint studies with Ianzini/MacKay, our and Hausmann
labs in Heidelberg [78,81]. In particular, it was shown that HeLa cells polyploidize in response to this
irradiation hit, while cell clonal regrowth starting from day 7–9 is provided by de-polyploidization of a
small proportion of still-persisting giant cells. In the current research, following treatment of HeLa
cells with a single dose of 10 Gy irradiation, cells were sampled and FISH was applied for centromeres
of three chromosomes #6, #10, #X (presented as triples without markers in a HeLa carcinoma genome).
The relative proportions were determined in 500–800 cell nuclei for each chromosome label per nucleus.
The representative FISH patterns of triploid, diploid and tetraploid nuclei are shown on Figure 2.
As seen in Figure 3A, the non-treated population consisted on average of 94% cell nuclei, trisomic
by all three centromeric-labels (NB: hexa-somy indicating to triploidy cycling was also observed),
however a very small proportion of diploid (disomic) and tetraploid (tetrasomic) cell nuclei and a
negligible amount of haploidy (monosomy) were also present. At 48 h after 10 Gy irradiation the
proportion of triploid cells decreased to 88% on average, while the proportion of diploid and tetraploid
cells correspondingly increased. In addition, a tiny subpopulation of haploid nuclei also appeared
(Figure 3A). When analyzed by χ-squared test (Table 2), the change of each label from non-treated
culture to 48 h post-irradiation showed its statistical significance, while all three labels changed in
accord. This leads us to suggest that triploid cells began the rearrangement of the whole genomes to
produce diploid and tetraploid fractions.
We were therefore interested to see if and how this tendency developed and examined the DNA
ploidy by in situ cytometry on further days after irradiation.
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Figure 2. Representative fluorescent in situ hybridization (FISH) patterns revealing (A,B) triploid,
(C) diploid, and (D) tetraploid cell nuclei 48 h after 10 Gy hit in HeLa cells using centromeric labels for
three chromosomes, #6, 10, X.
Figure 3. Endoreduplication and emergence of diploidy in the near-triploid HeLa cell line after
10 Gy-irradiation. (A) The decrease of the proportion of triploid nuclei and a corresponding increase of
the proportion of diploid and tetraploid cell nuclei are presented as an average value for chr #6, #10, #X
cen-labels in non-treated controls and 48 h after irradiation (t-student-test, p < 0.05). Percentage of cells
is presented in logarithmic scale. (B) DNA content (presented as integrated optical density in arbitrary
units) in giant cell nuclei on day four post-irradiation. The ploidy of 2C, roughly corresponding to ~3n,
was determined from anaphase halves of bipolar mitoses of the control (n = 50). (C) Heterogeneity of
the giant cell sub-nuclei on day four post-irradiation (obtained from 116 giant cells as determined by
DNA cytometry, and expressed and converted for convenience into ~ploidy numbers showing triploid
(3n) and hexaploid (6n) nuclei along with about 50% of diploid nuclei and their multiples (2n, 4n, 8n);
(D) Non-treated HeLa cells harvested in sub-confluence, composed of the dominant 3n stemline, while
the diploid stemline endocycling to 8n is also seen (mostly accumulated in the 4n-fraction). On (C,D),
the diploid endocycling stemline fractions are enframed in red, while triploid, in green dashed boxes.
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Table 2. Statistically significant and concordant increase of the proportion of diploid and tetraploid
cell nuclei tested by FISH centromeres labels of three chromosomes at 48 h post 10 Gy irradiation of
HeLa cells.
Chromosome X Chromosome 6 Chromosome 10
Share of Cell Nuclei with a Certain







Diploid and tetraploid nuclei NT 19 3.1 17 3.1 23 3.4
Triploid and other cell nuclei NT 586 96.9 523 96.9 649 96.6
Diploid and tetraploid nuclei 48h 53 10.2 34 6.2 54 7.0
Triploid and other cell nuclei 48h 466 89.8 518 93.8 714 93.0
χ-squared test, p-value 2.4·10−20 3.6·10−5 3.7·10−12
3.3. Multinucleated Giant Cells Contain DNA with Odd and Even Ploidy Numbers
As reported previously [78], on the first day most irradiated Hela cells were delayed in the
G2-arrest, from day two, 82% of live-imaged HeLa cells (n = 645) underwent the chromosome-bridged
post-telophase bi-nucleation, becoming tetraploid and many started the asynchronous bipolar divisions
of two sub-nuclei (exemplified in Figure 4A). These divisions were also a-cytokinetic, and thus, by day
three, 70% cells became octoploid (composed typically of two 4C sub-nuclei), in the following days the
ploidy and multi-nucleation increased. By day 4–5, the multinucleated polyploid giant cancer cells
(PGCC) composed of ~50% of the population and contained largely 8C, 16C, 24C, and 32C DNA in
total (Figure 3B). DNA cytometry of individual sub-nuclei of the 4-day PGCCs reveals in them odd
and even n-value numbers. C-value was determined from anaphase halves of the DNA content in
bipolar mitoses of untreated cultures. Therefore, it should be kept in mind that for near-triploid HeLa,
a 2C value roughly corresponds to ~3n. Subsequently, the derived ploidy numbers of the sub-nuclei
were 2n, 3n, 4n, 6n, and 8n (Figure 3C). The sub-nuclei of PGCC were mostly bridged, indicating
their origin from a common mother. Live-imaging showed that only 3% of cells in 72 h underwent
fusion of non-sister cells [78]. Interestingly, the DNA histogram of the non-treated population taken
at sub-confluence on day six (Figure 3D), also showed the same odd and even fractions (except 2n),
however, the ploidy doubling fractions 6n and 8n were minor. The sub-nuclei in PGCCs with odd
and even genome numbers were often arranged in giant cells radially and also frequently contained a
near-haploid subnucleus (rarely two-three of them), and a few micronuclei (Figure 4B,C).
In summary, a genotoxic challenge apparently caused the entrance of HeLa cells into endomitotic
a-cytokinetic cycles, starting from bi-nucleated on day two and reaching by day three majorly 8C/12n
and by day 4, 16C/24n ploidy. This response was heralded by the emergence of the increasing number
of diploid, tetraploid, and octoploid subnuclei coexisting with triploidy (and also haploidy) in the
same PGCCs. How could they achieve that? The answer was likely found in tripolar mitosis.
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Figure 4. Divisions and multi-nucleation of the genotoxically damaged tumor cells. (A) HeLa cell, on
day two post-irradiation (10 Gy): One subnucleus in a bi-nucleated cell is being divided (arrow). (B) A
processed for image analysis (DNA bridges were deleted) multinucleated giant HeLa cell nucleus on
day six post-irradiation containing sub-nuclei with even and odd proportions of DNA content, along
which a near-haploid (~1C) sub-nucleus and a micronucleus (Mn) were seen; (C) A processed for image
analysis (DNA bridges were deleted) multinucleated giant HeLa cell on day nine post-irradiation
containing four ~3n and three ~4n sub-nuclei with a similar sum DNA content; (D) The anaphase of
the multipolar mitosis of an irradiated HeLa cell with chromosome bridges between the karyokinesis
products of three bilobed groups, a finding indicative of the pair-wise fusion of segregated neighboring
genomes (stained with toluidine blue for DNA). The arrows show indentations in the bridges between
these pairwise fused products of three karyotomies due to incomplete or ongoing cleavage by radial
cytotomy; (E,F) Radial cleavage furrows bringing three Aurora KB-positive mid-bodies to the fused
one of their spindle poles together, potentially segregating the progeny with pedogamically fused
bilobed nuclei; (G) The diplochromosomic metaphase of a HeLa cell on day five post-irradiation
(10 Gy) (stained with Toluidine blue for DNA), resembling the diakinetic stage of meiosis with often
intertwisted or DNA-bridged (arrows) two pairs of cohesed sisters. On insert enlarged: (a) The
enframed bridged diplochromosome and an example of the chiasma found between diplochromosomes
of the irradiated Namalwa cell line; (H) Two subsequent divisions of the tetraploid sub-nucleus of a
giant Namalwa cell to a haploid pair of nuclei on day five post-irradiation (10 Gy) are seen, displaying
two persisting mid-bodies (shown by the arrows). Persistence of two subsequent mid-bodies and
~ haploidy in DNA content of the final anaphase figures suggest that the second division closely
followed the first division, omitting the S-phase. This sample was collected after 2-h treatment with
the proteasome inhibitor—lactacystin; The brightness in the DAPI channel was enhanced to highlight
small nuclei of the second anaphase; (I) The FISH sample for centromeres #6 and #10 of HeLa cells on
day four post-irradiation (10 Gy) shows (arrows) haploid (monosomic) and diploid (disomic) lobes of a
sub-nucleus resulting after multipolar karyokinesis. Bars = 10 µm. Figure 4A–C,H are reproduced
from [78], with permission of the publishers.
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3.4. Tripolar Mitosis of Endoreduplicated Cells May Convert Triploidy into Diploidy
Along with rare bipolar divisions, tripolar mitotic figures were seen in irradiated HeLa cells
more often than in control, at the end of the second day and onwards, until recovery of the triploid
clonogenic cell line. In some tripolar ana-telophase-like figures 48 h after irradiation, the chromosome
bridges were observed between three bilobed chromosome groups, indicating the pairwise fusion of
karyokinesis products (chromosome groups of a similar size) at each of three neighbor poles (Figure 4D).
The arrowed indentations of the chromosome bridges between these pairwise fused products are due
to incomplete, failed or ongoing cleavage by the radial cytokinesis. Cytometry revealed that three
bilobed groups contained equal (with 4% variation) DNA content corresponding ~2n, testifying to
the division of the replicated near-triploid cell into three diploid groups, where each likewise was
formed by the fusion of two haploid genomes (6n:3 = 2n). The radial cleavage furrows potentially
segregating the progeny with fused bilobed sub-nuclei and bringing three mid-bodies together are seen
in (Figure 4E,F). Most tumor segregations appeared less precise, however, the reported observation
shows namely that the tripolar mitosis of a replicated triploid 6n cell can convert triploidy into diploidy
demonstrating a pair-wise fusion of haploid genomes (see schematic on Figure 5, central upper figure).
If endoreduplication forms a larger 8C/12n cell, it can potentially produce by tripolar mitosis three
4n cells (12n:3 = 4n) or by tetrapolar mitosis four 3n cells (12n:4 = 3n). This may have occurred
with the nucleus of a PGCC on Figure 4C containing four 3n and three 4n sub-nuclei, each group
making the same 12n (~8C) DNA amount as measured by DNA cytometry. Those apparently represent
the products of tripolar and tetrapolar divisions of two 8C subnuclei in the same giant cell. The
prerequisites for such whole genome rearrangements would be the grouping and segregation of the
haploid chromosome entities and non-separation of sister chromatids. Therefore, it is worth to mention
as shown previously, that the chromosomal ends in acytokinetic multipolar mitoses of Hela cells were
usually seen closed [12,81].
So, we found here that near-triploid HeLa cells begin to increasingly produce the diploid and
tetraploid subfractions after irradiation, likely by a-cytokinetic tripolar mitosis of near-triploid cells
endoreduplicated to 6n and 12n and that their proportion increased from ~ 6% on day two to ~40–50%
on days 3–6. Thus, a tetraploid fraction composed of doubled parental genomes (~4nXXYY) could be
reconstituted from a triploid one. It could further enter pseudo-meiosis and potentially produce a
recombined unreduced diploid maternal pseudo-gamete and recombined reduced paternal haploid
pseudo-gamete (this process is schematically represented for a male tumor on Figure 1). This process
can take place either in the individualized cells—the diplochromosomic metaphases segregating
bi-chromatids (presented on Figure 4G) may have a relationship to this process. However, it is not
excluded that the whole pseudo-meiosis (recombination and reduction), as well as the digyny-like
pedogamic process (fusion between an unreduced diploid “maternal gamete” and a haploid reduced
“paternal gamete”), can take place at the site—on the platform of a polyploid giant cancer cell. A
two-step asymmetric reduction division from a PGCC in irradiated lymphoma cells (reproduced here
on Figure 4H) and occasional finding of two-parted HeLa giant cells sub-nuclei composed from a
monosomic and disomic parts seen by centromere #6 and #10 FISH (Figure 4I) provide a hint for such
an option. A non-sister fusion between diploid and haploid cells is not excluded as well, taking into
consideration the very rare, but still found in vivo (Figure S2) divisions of free haploid tumor cells.
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Figure 5. The Digyny Concept of meio-mitosis applied to near-triploid male tumor cells. (1) A digynic
triploidy tumor cell line (3nXXY) undergoes mitotic cycles replicating and segregating sister chromatids
for growth of the tumor mass. To perform recombinative renewal, it first closes telomere ends, and
after replication segregates the genomes of the 3nXXY(x2) cell in (2) tripolar mitosis as 2:2:2 by pairwise
fusing the haploid whole genome products of karyokinesis (red circles for arbitrary maternal, green,
for paternal genomes) at each pole. (3) A diploid progeny (2nXY) endoreduplicates to 4n XXYY,
and to 8n; a triploid subnucleus can also endoreplicate to 6n; 1n Y can be also (rarer) produced in
tripolar mitosis (3:2:1); (4) 4n as a subnucleus of the polyploid giant cancer cell (PGCC) or as a free
cell enters the recombinative pseudo-meiosis followed by one-step reduction division (for “maternal”
sub-nucleus) and two-step reduction (for “paternal” sub-nucleus). A digyny-like fusion in 3n XXY
subcell is processed (a dashed box). Alternatively (less likely), one non-recombined 1nY subnucleus
from tripolar mitosis of a triploid cell (3:2:1) can fuse with two recombined, unreduced maternal
genomes of a pseudo-meiotic diploid sub-cell. (5) A renewed digynic triploid cell restarts mitotic
cycling, the process constitutive for tumor near-triploidy and favoring cell survival by compensating
lethal recessive mutations. The near-diploid tumors can also enter this hybrid cycle induced through
endoreduplication and multipolar mitosis, and thus be converted into triploid digynic stem-line if
influenced by senescence, oncogenes, and genotoxic therapy.
3.5. Summary of Results
The presented results provide the first evidence that in somatic human tumors the diploid and
triploid compartments may constitutively co-exist and exchange the whole genomes in the same tumor.
The study of irradiated near-triploid HeLa cells revealed that diploid subcells are produced after
genotoxic insult in induced endopolyploid tumor cells through euploid whole genome segregations
and fusions in tripolar mitosis.
4. Discussion
From the study of 15 male malignant tumor types with near-triploid XXY karyotypes assembled
from the Mitelman karyotype database presented in the accompanying paper [10] and DNA cytometry
of resistant triploid breast cancer, we suggested the association of the near-triploid XXY karyotypes
(XXX for females) with a digyny-like pedogamic process—somewhat like an aberrant unisexual
“fertilization”. From the literature analysis and experimental evidence presented here the whole
process can be deduced as follows (Figure 5). The mitotically cycling near-triploid “digynic” tumor
cell (Figure 5(1)), when challenged by stress, undergoes tripolar mitosis for the reconstruction of
diploidy by segregating and fusing haploid genomes (Figure 5(2)). For that, these cells possibly
use the platform of transient multinucleated giant cells enclosing resulting diploid and triploid
sub-nuclei and their replicas (Figure 5(3)). In turn, the replicated diploid subnuclei/cells (4n) are
capable of undergoing the recombinative pseudo-meiosis and creating pseudo-gametes. The parental
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pseudo-gametes (unreduced maternal and reduced paternal) pedogamically fuse, to reconstitute
the triploidy digynic-like tumor stem line 3n XXY (Figure 5(4)). The latter, representing a triploid
“parthenote”, stops further differentiation and returns in the genetically renewed, recombined form
into a mitotic cycle (Figure 5(5)). On recovery, this mitotic clonogenic cycling becomes dominant
again, increasing the tumor mass. It follows, that diploid and triploid sub-lines exchange whole
haploid genomes. Somewhat in accord, Kroeger et al. [82] recently published the necessity for a
hybrid epithelial-and mesenchymal state (Snail–Wnt-driven) for the growth of basal breast cancer
suggesting the epithelial and mesenchymal cells cooperate as two sub-populations of tumors. Could
they correspond to the diploid and triploid sub-lines? This is a question for future projects. Our
hypothesis was stimulated by the previously published study of the chemoresistant triploid breast
cancer [9] and the polyclonal karyotypes in male renal carcinoma, which were assessed here. Moreover,
single-cell transcriptome sequencing tumor analysis also points to the polyclonal adaptive nature of
cancer chemoresistance [83]. The current study on irradiated near-triploid HeLa cells brought us to
PGCC—an analogue by its expression profile of the blastula embryo [35,36,47] and to tripolar mitoses
in them.
Further, we should compare our results with a series of studies performed in the late 1960s
to the mid-1970s [84–87], which essentially coincide with our observations. The authors used the
multiple primary cultures of normal diploid mouse fibroblasts and Rhesus monkey kidney epithelial
cells, applying DNA densitometry and cytogenetic analysis. They found that, contrary to bipolar
mitosis occurring in diploid cells, the endoreduplicated tetraploid cells emerging in senescing cultures
in a small proportion (~3% cells) from day 15–20 majorly undergo tripolar mitoses. Those were
analyzed without applying spreading and spindle poisons. The euploid segregation of the genomes in
haploid, diploid, and triploid ana-telophase groups by tripolar mitosis was reported in this article
series published by two groups on two mammalian species. The genetic material of the initially diploid
culture is most often segregating in tripolar mitosis as the multiples of haploid genomes in a 3n:3n:2n
ratio—so, through endoreduplication the diploidy gives birth to triploidy. In turn, the resulting triploid
cells most often segregate the genomes (after re-replication) by tripolar mitosis in a 2n:2n:2n ratio, thus
triploidy could recurrently give birth to diploidy. This is namely the same as what we have found
as a “nervus probandi” on Figure 4D for near-triploid endoreduplicated HeLa cells. Segregations of
triploids to haploidy were also found by these authors (3n:2n:1n), but far less frequently. Although,
as they also found the cytokinesis was defective or delayed, all subcells segregated after tripolar
mitosis still could further divide by bipolar mitosis, except haploid YO, which existed only within a
multinucleated mother. Importantly, Palitti and Rizzoni [85] scored the frequency of different variants
of euploid segregations in tripolar mitoses of tetraploid and triploid cells from 77 primary diploid
mouse cultures and tested as the null hypothesis if those segregate the genomes (i) in random and
(ii) sending sister chromatids to different poles. This model was disproved by real scores—segregations
were not random (some variants were several-fold preferred over the theoretically possible ones) and
the chromatids could be not (or preferentially were not) separated, indicating a weak spindle.
Rizzoni et al [87] concluded that in mammalian somatic euploid cells there seems to exist a
supra-chromosomal organization of the genome in haploid sets, which displays itself in the euploid
segregations through multipolar mitosis. As to the analysis of segregation of the sex chromosomes, [86],
the digynic formula 3nXXY was preferentially found, while 3n XYY (diandry) also occurred but two
times less frequently. Moreover, the authors were highly surprised to reveal XX-diploid cells in male
mouse fibroblast cultures after multi-polar mitoses of polyploid cells.
Finally, Pera and Scholtz [88] described the sharp conversion of the normal male mouse diploid
fibroblast cell line into triploidy after ~12 months of cultivation (likely occurring due to oncogenic
transformation). Two triploid cell lines comprising 85% of the population could be distinguished
and isolated, one with the karyotype 3n XXY, the other with 3n XYY. In ~1% of the culture, diploid
cells with two X or two Y chromosomes were found. Haploid, tetraploid, hexaploidy, and octoploid
mitoses were also observed at a low percentage. The involvement of the meiotic component in tripolar
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segregations of diploid mammalian cells, which may be responsible for XXY karyotype and diploid XX
male cells, was suggested.
We also decided to additionally extract from the Mitelman database the malignant tumor
karyotypes with double X and double Y tetraploid and diploid karyotypes presented in Table 3 for
comparison with the above literature data. Y0 haploid karyotypes were never encountered, and also
YY were practically absent (or could exist as an exception only with fragmented X-chromosome), while
XX diploid karyotypes were present in seven of 15 tumor cohorts and XXYY were present everywhere
(except gastric cancer).
Summarizing this part of the discussion, we conclude that the German and Italian groups of the
1970s revealed on normal mammalian cells the same regularity, which we were able to “fish out” using
the X chromosome disomy “hook” from the 2928 male tumor karyotypes on the digyny-like origin of
triploidy from Mitelman database. Without this approach, the somatic digyny in tumors is obscured
by the overlaying chromosome instability and not easily seen.
Namely, these data presume the segregation of parental genomes as suprachromosomal
entities, reconstruction of diploidy from triploidy and vice versa through multipolar divisions
of endoreduplicated cells, as well as a preferential doubling of maternal genomes in male tumors,
shown and discussed in [10].
The details of a pseudo-meiotic process remained less clear. The existence of a pseudo-meiotic
process in irradiated HeLa cells was studied by Ianzini et al. [53] in collaboration with our laboratory,
mostly by qPCR, where up-regulation of MOS, cyclin B1, meiotic cohesin REC8 (increased 3-fold
on day three and 10-fold on day five, with repeating peaks on day 10 and 25), meiotic recombinase
DMC1, and SYCP3 were found. The overexpressed meiotic protein SCP3 was even suggested as
a prognostic marker for cervical carcinomas [89]. However, pseudo-meiosis in tumors seems to be
occurring even without conventional synaptonemal complexes [12]. More studies on this issue are
needed in the future.
Table 3. The proportions of tetraploid and diploid karyotypes possessing two X chromosomes, and the
almost-absent karyotypes with two Y-chromosomes for 15 male malignant tumor cohorts from the
Mitelman database.
Malignant Tumor Type Number ofKaryotypes XXYY (%) X,−Y,+X (%)
YY,−X (or with
Fragmented X) (%)
Seminoma 78 12.82 2.56 0.00
Osteosarcoma 61 6.56 0 0.00
Lung carcinoma 237 2.95 0.84 0.00
Gastric carcinoma 74 0.00 4.05 0.00
Head and neck squamous cell
carcinoma 191 3.14 0 0.00
Colon adenocarcinoma 98 3.06 3.06 0.00
Transitional cell carcinoma 104 0.96 0 0.00
Chondrosarcoma 85 5.88 0 0.00
Malignant melanoma 134 1.49 0.75 0.00
Glioblastoma 215 6.51 0 0.00
Renal carcinoma 577 1.39 0.87 0.17
Mesothelioma 72 5.56 0 0.00
Rhabdomyosarcoma * 92 30.43 3.26 1.09
Ewing sarcoma 228 3.51 0 0.00
Liposarcoma 147 3.40 0 0.00
* Rhabdomyosarcoma is an outlier as originating from multi-nuclear cells.
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Interestingly, concerning meiotic kinase MOS and quite in accord with our current data,
Vitale et al [90] found in colon cancer p53-null cells treated with nocodazole that multipolar mitosis in
induced transient tetraploidy cells was dependent on upregulation of this kinase, which inhibited the
coalescence of supernumerary centrosomes and finally favored selection of less aneuploid progeny.
Multipolar mitosis in tumors has been extensively studied and explained by the dysfunctional
spindle assembly checkpoint leading to nearly random segregation of sister chromatids between
poles [91,92], then the role of cytokinesis failure in the asymmetric segregation of chromosomes
into two daughter cells was highlighted [93]. However, it seems that the rules applicable to the
regulation of mitosis as such may be non-applicable for tripolar mitosis in the germ-like PGCCs.
Further detailed studies are needed but currently it appears that in the latter not the chromatids but the
genomes are segregated, reassorted and fused in a pedogamic manner at the background of the weak
spindle checkpoint. The same can be said about a-cytokinesis. In fact, radial cytokinesis releasing
progeny from PGCC is postponed [12] and, by analogy with such in Drosophila egg chambers [94],
is inherently unequal.
5. Conclusions
Considering the nature of the complex process involving the PGCC, it seems to be evolutionary
pre-programmed and aimed for the atavistic response mode for cell survival in adverse conditions,
operating with the whole genomes in a parasexual life cycle of tumor cells. The molecular background
of the endoreduplicated pseudo-blastula in the conditions of oncogenic and/or genotoxic stress likely
favors the adaptive triploid digyny-like process assisted through tripolar mitosis. The exchange
between reproductive (with meiotic elements) diploid and clonogenic triploid subfractions supports
the tumor immortality by recombinative genetic variation, on one side, and protects from recessive
lethal mutations with the selection of the fittest clones, on the other side. These whole-genome
rearrangements do not exclude chromosome instability because stochastic noise and occasional
chromothripsis are also inevitably needed for the optimization of the inheritance system [95].
The digyny concept also does not contradict but essentially complement the paradigm of the
somatic mutation/clonal selection origin of cancer.
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